Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia

INTRODUCTION: PRESENCE was a phase 2 clinical trial assessing the efficacy of mevidalen, a D1 receptor positive allosteric modulator, for symptomatic treatment of Lewy body dementia (LBD). Mevidalen demonstrated improvements in motor and non-motor features of LBD, global functioning, and actigraphy-...

Descripción completa

Detalles Bibliográficos
Autores principales: Battioui, Chakib, Man, Albert, Pugh, Melissa, Wang, Jian, Dang, Xiangnan, Zhang, Hui, Ardayfio, Paul, Munsie, Leanne, Hake, Ann Marie, Biglan, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Reports – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315006/
https://www.ncbi.nlm.nih.gov/pubmed/37404864
http://dx.doi.org/10.1159/000529623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315006/
https://www.ncbi.nlm.nih.gov/pubmed/37404864
http://dx.doi.org/10.1159/000529623

Ejemplares similares